| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in OpenEMR up to 5.0.0. It has been rated as problematic. This issue affects some unknown processing. Performing a manipulation results in cross site scripting (Reflected). This vulnerability is identified as CVE-2017-1000240. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability, which was classified as problematic, was found in OpenEMR up to 5.0.0 (Business Process Management Software). This affects an unknown function. The manipulation with an unknown input leads to a cross site scripting vulnerability (Reflected). CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
The application OpenEMR is affected by multiple reflected & stored Cross-Site Scripting (XSS) vulnerabilities affecting version 5.0.0 and prior versions. These vulnerabilities could allow remote authenticated attackers to inject arbitrary web script or HTML.
The bug was discovered 05/23/2017. The weakness was released 11/17/2017 (Website). The advisory is shared at wizlynxgroup.com. This vulnerability is uniquely identified as CVE-2017-1000240 since 11/16/2017. It is possible to initiate the attack remotely. The successful exploitation requires a authentication. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
The vulnerability was handled as a non-public zero-day exploit for at least 177 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Entry connected to this vulnerability is available at VDB-109642. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Name: ReflectedClass: Cross site scripting / Reflected
CWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
OpenVAS ID: 60138
OpenVAS Name: OpenEMR <= 5.0.0 Multiple Vulnerabilities
OpenVAS File: 🔍
OpenVAS Family: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
05/23/2017 🔍11/16/2017 🔍
11/16/2017 🔍
11/17/2017 🔍
11/18/2017 🔍
12/08/2019 🔍
Sources
Advisory: wizlynxgroup.comStatus: Not defined
CVE: CVE-2017-1000240 (🔍)
GCVE (CVE): GCVE-0-2017-1000240
GCVE (VulDB): GCVE-100-109641
See also: 🔍
Entry
Created: 11/18/2017 08:54Updated: 12/08/2019 10:34
Changes: 11/18/2017 08:54 (61), 12/08/2019 10:34 (1)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.